Items per page
1 - 29 of 29
Title Published in Access level OA Policy Year Views Downloads
Role of Hydrogen Sulfide in Oncological and Non-Oncological Disorders and Its Regulation by Non-Coding RNAs: A Comprehensive ReviewNon-coding RNA
accessLevelPublic
2024 163 36
GSDMD is associated with survival in human breast cancer but does not impact anti-tumor immunity in a mouse breast cancer modelFrontiers in immunology
accessLevelPublic
2024 169 46
Dual targeting of H2S synthesizing enzymes; cystathionine β-synthase and cystathionine γ-lyase by miR-939-5p effectively curbs triple negative breast cancerHeliyon
accessLevelPublic
2023 182 34
Role of Cystathionine β-Synthase and 3-Mercaptopyruvate Sulfurtransferase in the Regulation of Proliferation, Migration, and Bioenergetics of Murine Breast Cancer CellsAntioxidants
accessLevelPublic
2023 307 67
Activation of endogenous glucocorticoids by HSD11B1 inhibits the antitumor immune response in renal cancerOncoimmunology
accessLevelPublic
2023 227 67
PEGylated Gold Nanoparticles Target Age-Associated B Cells In VivoACS nano
accessLevelPublic
2022 357 50
Inhibition of IL-1β release from macrophages targeted with necrosulfonamide-loaded porous nanoparticlesJournal of controlled release
accessLevelPublic
2022 387 320
HMGB1 promotes CXCL12‐dependent egress of murine B cells from Peyer's patches in homeostasisEuropean Journal of Immunology
accessLevelPublic
2021 247 96
The interleukin-1 cytokine family members: role in cancer pathogenesis and potential therapeutic applications in cancer immunotherapyCytokine & growth factor reviews
accessLevelPublic
2021 265 127
Mesoporous Silica Nanoparticles as pH-Responsive Carrier for the Immune-Activating Drug Resiquimod Enhance the Local Immune Response in MiceACS Nano
accessLevelPublic
2021 390 487
Silver-Containing Titanium Dioxide Nanocapsules for Combating Multidrug-Resistant BacteriaInternational Journal of Nanomedicine
accessLevelPublic
2020 478 161
Médiateurs de l'aspirine dans l'arsenal anticancéreux ?Revue médicale suisse
accessLevelPublic
2020 313 392
Polymer-coated gold nanospheres do not impair the innate immune function of human B lymphocytes in vitroACS Nano
accessLevelPublic
2019 445 455
Development of resiquimod-loaded modified PLA-based nanoparticles for cancer immunotherapy: A kinetic studyEuropean Journal of Pharmaceutics and Biopharmaceutics
accessLevelPublic
2019 578 511
Amphiphilic nanoparticle delivery enhances the anticancer efficacy of a TLR7 ligand via local immune activationBiomaterials
accessLevelPublic
2019 530 513
CCL22 controls immunity by promoting regulatory T cell communication with dendritic cells in lymph nodesJournal of Experimental Medicine
accessLevelPublic
2019 482 313
Harnessing the immune system to fight cancer with Toll-like receptor and RIG-I-like receptor agonistsPharmacological Research
accessLevelPublic
2019 541 963
Bionanomaterials for the Delivery of Cancer ImmunotherapyChimia
accessLevelPublic
2019 426 221
Hook length of the bacterial flagellum is optimized for maximal stability of the flagellar bundlePLOS Biology
accessLevelPublic
2018 478 267
Polymer-based nanoparticles loaded with a TLR7 ligand to target the lymph node for immunostimulationInternational Journal of Pharmaceutics
accessLevelPublic
2018 638 627
Engineered hybrid spider silk particles as delivery system for peptide vaccinesBiomaterials
accessLevelPublic
2018 563 393
Antimicrobial silver-filled silica nanorattles with low immunotoxicity in dendritic cellsNanomedicine
accessLevelPublic
2017 539 460
Arginase inhibition suppresses lung metastasis in the 4T1 breast cancer model independently of the immunomodulatory and anti-metastatic effects of VEGFR-2 blockadeOncoimmunology
accessLevelPublic
2017 239 133
NAB2 is a novel immune stimulator of MDA-5 that promotes a strong type I interferon responseOncotarget
accessLevelPublic
2017 503 183
A rapid screening method to evaluate the impact of nanoparticles on macrophagesNanoscale
accessLevelPublic
2017 498 359
Reprogramming of TLR7 signaling enhances antitumor NK and cytotoxic T cell responsesOncoimmunology
accessLevelPublic
2016 232 80
TLR7-based cancer immunotherapy decreases intratumoral myeloid-derived suppressor cells and blocks their immunosuppressive functionOncoimmunology
accessLevelPublic
2016 225 106
P68. A new EGFR - EpCAM bispecific antibody enhances the efficacy of adoptive T-cell therapy in a murine gastric tumour modelJournal for immunotherapy of cancer
accessLevelPublic
2014 23 16
Chronic progressive HIV-1 infection is associated with elevated levels of myeloid-derived suppressor cellsRetrovirology
accessLevelPublic
2012 25 19
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack